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Association of serum cortisol and dehydroepiandrosterone sulfate (DHEAS) levels with
psychological stress in patients with vitiligo
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Background/aim: Vitiligo is a depigmentation disorder that leads to serious psychological burden in patients, who are frequently
reported to have depression and anxiety. The aim of this study was to investigate the association between stress-related hormone levels
and psychological stress in vitiligo.
Materials and methods: In this study 46 vitiligo patients and 46 controls were enrolled; their cortisol, dehydroepiandrosterone sulfate
(DHEAS), and cortisol/DHEAS levels were measured. Psychological burden was assessed by the Beck Depression Inventory and
Perceived Stress Scale.
Results: Patients and controls did not differ in terms of cortisol, DHEAS, or cortisol/DHEAS. Patients had higher perceived stress than
controls but did not differ in terms of depression scores. Correlation analyses revealed that cortisol/DHEAS correlated positively with
perceived stress (P = 0.009, r = 0.272). The correlation between cortisol/DHEAS and perceived stress was stronger in the patient group
(P = 0.013, r = 0.363) and close to zero among controls. In regression analyses, lower depression and higher perceived stress were shown
to predict cortisol/DHEAS values.
Conclusion: Vitiligo patients significantly differed from the healthy population in terms of hormones and psychological distress. There
was also an association between perceived stress and cortisol/DHEAS ratio in vitiligo. Abnormality of hormonal response to distress
lowers DHEAS, which is known for its antioxidant properties, a possible mechanism for vitiligo development. Another important
finding is the significance of using the composite variable cortisol/DHEAS, which seems to be more sensitive to distress than each of its
components. We suggest its use in future studies on psychological distress–hormone relationships.
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1. Introduction
Stress and hormones are known to be closely related,
and recent studies show that, in addition to cortisol, the
major stress hormone dehydroepiandrosterone sulfate
(DHEAS) may also play a role in stress [1,2]. Psychogenic
stress is also thought to be an important factor in vitiligo,
which is an acquired pigmentation disorder characterized
by circumscribed depigmented macules and patches
on the skin. One of the most popular pathogenetic
mechanisms suggested for the pathophysiology of vitiligo
is oxidative stress and hydrogen peroxide accumulation,
leading to damage in melanocytes in the epidermis [3,4].
The cosmetic disfigurement is known to lead to serious
psychological burdens in patients with vitiligo, who
are frequently reported to have depression and anxiety
disorders, which may in part be caused by stigmatization
of the disease [5–7]. It is also possible that psychological

distress or depression, through their effects on stress
hormones, may have a role in the development of vitiligo.
Based on the existing literature, we sought to
investigate the association between stress-related
hormone levels (serum cortisol and DHEAS) and
psychological stress measures in vitiligo patients. To
our knowledge, DHEAS levels were not evaluated in
vitiligo before. The relationship between hormone levels
and clinical subtypes of vitiligo was also evaluated. Our
hypotheses were as follows:
1. We will find differences in stress-related hormone
levels (i.e. cortisol and DHEAS) between vitiligo patients
and controls.
2. We will find higher psychological distress and
depression in vitiligo patients than controls.
3. Psychological distress and depression will be related
to hormone levels in vitiligo patients, but not in controls.
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2. Materials and methods
2.1. Sample and study design
2.1.1. Samples
Vitiligo patients who had been admitted to dermatology
outpatient clinic of the Hacettepe University Hospital in
2010 and 2011, who were older than 18 years of age, and
who had given consent for participation were included
in the study. Sex- and age-matched controls were chosen
from among healthy individuals.
2.1.2. Assessments
Exclusion criteria were defined as the coexistence of
adrenal, pituitary, and psychiatric diseases or polycystic
ovary syndrome (PCOS). In order to exclude a probable
diagnosis of PCOS, females with abnormally high free
testosterone levels, irregular menstrual periods, and
hirsutism were excluded. All participants who had
abnormally high free testosterone and DHEAS levels, any
systemic chronic disease, systemic infection, pregnancy,
or a history of medication use including systemic steroids,
oral contraceptives, and psychiatric drugs within 3 months
prior to the study were excluded.
2.1.3. Procedure
All participants were asked to avoid heavy exercise,
cigarette smoking, and alcohol intake prior to the day of
blood sampling. Peripheral venous blood samples were
taken from patients and controls in the morning between
0800 and 0900 hours after a 12-h fasting period. Morning
cortisol, DHEAS levels, and cortisol/DHEAS ratios were
analyzed at the Hacettepe University Hospital Central
Laboratories by chemiluminescence method using the
IMMULITE 2000 assay. Psychological distress was assessed
by the Beck Depression Inventory (a 21-item self-report
measuring the intensity of depressive symptoms) and the
Perceived Stress Scale (a 10-item psychological instrument
for measuring perceptions of stress, designed to measure
how unpredictable, uncontrollable, and overloaded
respondents find their lives) [8,9]. Generalized vitiligo was
defined as vitiligo with acrofacial lesions (distal fingers and
periorificial areas) and/or widely distributed patches or

with a mixed pattern of both involving more than 10% of
the body surface area (BSA). Focal vitiligo was defined as
one or more macules in only one body area or dermatome
and with less than 10% BSA involvement. Ethical approval
was given by the Hacettepe University Ethics Board (LUT
12/04-22).
2.2. Statistical analysis
Outcome measures were mean DHEAS and cortisol
values. A composite variable that is commonly used in
the literature, the cortisol/DHEAS ratio, was also used as
an outcome variable. In order to test our hypotheses, we
compared hormone levels between patient and control
groups using t-tests. Correlation analyses were carried
out between hormone levels, psychological distress, and
perceived stress scale scores. Predictors of hormone levels
were assessed using linear regression analyses. SPSS 17.0
was used in the statistical analyses.
3. Results
A total of 46 vitiligo patients (27 males and 19 females)
and 46 sex- and age-matched controls were enrolled in the
study. Serum cortisol, DHEAS, and cortisol/DHEAS levels
in the patient and control groups are shown in Table 1.
Contrary to our first hypothesis, the patient and control
groups did not differ in terms of morning cortisol, DHEAS
levels, or cortisol/DHEAS ratios.
Our second hypothesis was partly supported; the
patient group reported higher perceived stress than
controls, although the two groups did not differ in terms
of depression scores.
To test our third hypothesis, we ran correlation analyses
in the total group first and then we repeated the same
analyses within patients and controls separately (Table 2).
In the total sample (n = 92), cortisol/DHEAS correlated
positively with perceived stress (DHEAS tended to relate
negatively to psychological distress). Cortisol levels did
not show any correlations with distress or depression.
When examined separately, the correlation between
cortisol/DHEAS and perceived stress was stronger in the
patient group and close to zero among controls (Figure).

Table 1. Comparison of study group and controls according to hormone levels and psychological
stress.
Patients, n = 46
(mean ± SD)

Controls, n = 46
(mean ± SD)

P

Cortisol

14.05 ± 5.03

13.78 ± 6.24

0.446

DHEAS

192.31 ± 106.07

224.82 ± 109.15

0.158

Cortisol/DHEAS

0.12 ± 0.14

0.08 ± 0.06

0.113

Perceived Stress Scale

18.43 ± 6.24

15.96 ± 5.02

0.097

Beck Depression Inventory

10.46 ± 8.87

7.33 ± 7.53

0.095
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Table 2. Correlations between hormone levels and psychological stress in patient and control groups.
Subjects
Perceived Stress Scale
Patient group
Beck Depression Inventory
Perceived Stress Scale
Control group
Beck Depression Inventory
Perceived Stress Scale
Total
Beck Depression Inventory

Cortisol

DHEAS

Cortisol/DHEAS

P

0.406

P

0.219

P

0.013

r

0.126

r

–0.185

r

0.363

P

0.154

P

0.930

P

0.179

r

0.216

r

0.13

r

0.040

P

0.054

P

0.351

P

0.735

r

–0.286

r

–0.141

r

–0.051

P

0.070

P

0.248

P

0.964

r

–0.27

r

–0.174

r

–0.07

P

0.499

P

0.069

P

0.009

r

–0.71

r

–0.19

r

0.272

P

0.696

P

0.342

P

0.654

r

–0.042

r

–0.101

r

0.048

r: Pearson correlation coefficient.

Figure. Correlation between cortisol/DHEAS and perceived stress in vitiligo patients and controls.

This suggests that the patient group was responsible for the
correlation observed.
To further test our third hypothesis, this time
controlling for the intervening variables, we ran regression
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analyses using cortisol, DHEAS, and cortisol/DHEAS as
dependent variables in turn. We wanted to see if group
membership (belonging to patient vs. control group)
predicted hormone levels, and if this prediction was
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independent of sex, age, or psychological distress. We
therefore entered the predictor (explanatory) variables in
three steps: group membership first, sex and age second,
and distress measures (depression and perceived stress)
in the last step (Table 3). The predictors of DHEAS and
cortisol/DHEAS were understandably similar: both were
predicted by sex and age. DHEAS levels were predicted
by younger age and being male, whereas cortisol/DHEAS
ratio was predicted by older age and being female. Cortisol
levels were predicted by being female, and there was a
trend for younger age. DHEAS was also predicted by
belonging to the control group, and there was a trend for
the opposite for cortisol/DHEAS. While neither cortisol
nor DHEAS were found related to psychological distress
measures, cortisol/DHEAS was predicted by both: lower
depression and higher perceived stress predicted cortisol/
DHEAS values.
We repeated the above analyses within patient and
control groups separately (Table 3), to see if there was a
differential prediction of hormone levels between groups.
The prediction of DHEAS and cortisol/DHEAS by age and
sex was similar to those of the total sample. The prediction
of cortisol/DHEAS by distress measures, however, was
limited only to the patient group: the prediction was
stronger in the patient group and was close to zero among
controls.
Finally, we examined the patient group to see if
illness-related variables such as extent of lesions, family
history, and illness duration had any effect on hormone

levels. Cortisol was not predicted by any of the variables.
Both DHEAS and cortisol/DHEAS were predicted by age
and sex. The only variable that was predicted by clinical
variables was DHEAS; shorter illness duration and more
generalized lesions predicted higher DHEAS levels (Table
4).
4. Discussion
The present study is the first to examine stress hormone
levels and their relationship to psychological distress
in vitiligo patients. Patients with vitiligo are frequently
reported to have depression and anxiety disorders, which
may in part be caused by stigmatization of the disease [5–
7]. However; to our knowledge, stress hormone levels and
their possible interactions in vitiligo have not been studied
in this patient population in the literature before. Although
the stress hormone levels did not significantly differ
between patients and controls, the regression analyses
taking into account other intervening variables showed
that the two groups actually differed in terms of DHEAS
levels; the control group had higher DHEAS levels. Since
the patient group reported higher psychological distress
than the control group, controlling for distress (and
depression) was warranted. Consequently, we found that
DHEAS levels in the control group were independent of
distress levels. However, this did not mean that distress
was independent of hormone levels. In within-group
analyses, perceived stress was related to cortisol/DHEAS in
the patient group, but not in the control group. Although

Table 3. Predictors of hormone levels in total group, patients, and controls.
Predictor variables

Cortisol

DHEAS

Cortisol/DHEAS

Total group

β

P

β

P

β

P

Group (1 = patients, 2 = controls)

–0.060

0.571

0.151

0.042

–0.151

0.100

Sex (1 = males, 2 = females)

0.263

0.018

–0.472

0.000

0.406

0.000

Age

–0.173

0.098

–0.598

0.000

0.274

0.003

Depression

–0.014

0.925

–0.001

0.988

–0.250

0.046

Perceived distress

–0.153

0.309

0.018

0.865

0.272

0.037

Patients

β

P

β

P

β

P

Sex (1 = males, 2 = females)

–0.166

0.369

–0.611

0.000

0.316

0.041

Age

–0.178

0.257

–0.584

0.000

0.325

0.014

Depression

0.202

0.365

0.113

0.418

–0.349

0.060

Perceived distress

0.058

0.810

0.026

0.862

0.465

0.023

Controls

β

P

β

P

β

P

Sex (1 = males, 2 = female)

0.445

0.002

–0.389

0.001

0.555

0.000

Age

–0.096

0.474

–0.601

0.000

0.256

0.051

Depression

–0.179

0.301

–0.095

0.513

–0.007

0.965

Perceived distress

–0.166

0.343

0.057

0.698

–0.118

0.481
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Table 4. Predictors of hormone levels in the patient group including clinical variables.

Predictor variables

Cortisol

DHEAS

Cortisol/DHEAS

β

P

β

P

β

P

Sex (1 = males, 2 = females)

0.241

0.146

–0.470

0.000

0.401

0.008

Age (years)

–0.256

0.131

–0.549

0.000

0.259

0.087

Illness duration (years)

0.088

0.637

–0.257

0.043

0.082

0.618

Body area affected (1 = <10%, 2 = ≥10%)

–0.294

0.160

0.281

0.045

–0.111

0.544

Family history of vitiligo (0 = no, 1 = yes)

–0.048

0.757

0.144

0.168

–0.104

0.455

Perceived distress (0–40)

0.023

0.927

–0.147

0.361

0.105

Depression (0–63)

–0.159

0.518

0.055

–0.277

0.206

we showed that vitiligo patients had lower DHEAS than
controls and were highly distressed, these points alone
cannot show that vitiligo is caused by distress or low
DHEAS, or both. Still, we believe it is important that the
stress and cortisol/DHEAS relationship was observed
in patients and not in controls, which could mean that
hormonal response to distress may be abnormally
elevated in some people, a possible mechanism for the
development of vitiligo. A further, although weak, support
for this speculation was observed in analyses looking
into disease severity: we observed a tendency for those
who had a longer illness duration to have lower DHEAS
levels. DHEAS is known for its antioxidant properties; it is
therefore reasonable to assume that lack of DHEAS may be
a reason for longer duration of illness, or lack of adequate
response to treatment [8–11].
One important finding of this study has to do with the
significance of using the composite variable of cortisol/
DHEAS. This ratio seems to be more sensitive to distress
than each of its components. We suggest its use in future
studies on psychological distress–hormone relationships.
Another
interesting
finding,
which
looks
counterintuitive, is about the relationship between DHEAS
levels and extent of the lesions. It seems that the more
generalized the lesions, the higher the DHEAS levels. This
relationship is independent of disease duration (which is

0.371
0.736

longer in the generalized type) and distress or depression
levels (those with generalized lesions tended to have lower
depression scores). Our definition of the extent of vitiligo
lesions was a dichotomous variable. It is possible that we
may have missed some correlations that could have been
found if we had measured the extent of lesions using a
finer (continuous) measure.
Our study has several limitations. The collected data
were cross-sectional. It was therefore not possible to reach
a definitive conclusion on causality. Low sample size
did not allow us to include more variables in regression
analyses; studies with larger samples are warranted.
In conclusion, the present study is the first to
examine the relationship between cortisol, DHEAS, and
psychological distress in vitiligo patients. Our results
provide some insight into the interaction between stress
hormones and psychological distress in the development
of vitiligo. Our conclusion is that hormonal response to
distress may be abnormally elevated in some people,
a possible mechanism for the development of vitiligo.
Studies with larger samples are needed to clarify the nature
of the proposed interaction.
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